Anny OrtizJan 248 minPharmaceutical InequalitiesA brief review of psychedelics’ biological and psychological mechanisms
Gabriel Lake CarterJan 123 minPharmaceutical InequalitiesDiscussions on Enacting Transdisciplinarity in Psychedelic Studies
Gabriel Lake CarterDec 15, 20223 minPharmaceutical InequalitiesMosaics of Support for Psychedelic Risk Reduction
Anny OrtizDec 6, 20228 minPharmaceutical InequalitiesReflections on how the Yaqui Intercultural Medicine Clinic came to be
Amanda PrattDec 1, 20229 minFrom the CollectionsPoints Interview: Philipp Rühr, Archival Researcher Network participant.
Gabriel Lake CarterNov 24, 20222 minConferences and EventsPlants as Psychoactives and Medicines: Touring Allen Centennial Gardens
Gabriel Lake CarterNov 1, 20226 minPharmaceutical InequalitiesTransdisciplinarity to Address Inequality in Psychedelic Studies
Points EditorsOct 25, 20222 minConferences and EventsTransdisciplinary Approaches for Psychedelic Experiences Lecture
Anny OrtizOct 18, 20225 minPharmaceutical InequalitiesThe toad boom: the false narrative of ancestral 5-MeO-DMT use
Points EditorsSep 23, 20221 minConferences and EventsPsychedelic Pasts, Presents & Futures Roundtable
Amanda PrattAug 2, 20222 minPharmaceutical InequalitiesRight Wing Psychedelia with Dr. Brian Pace and Dr. Neşe Devenot
Points EditorsMay 26, 20223 minCalls for PapersCFP: Psychedelic Capitalism: From Forest Retreat to Fortune 500 and Pharmacies
Anny OrtizMay 10, 20228 minPharmaceutical InequalitiesPsychedelics in the treatment of substance use disorders: the case of ibogaine